Breast Cancer Subtypes Identified by the ER, PR and HER-2 Status in Thai Women

Clinicopathologic Features of Breast Carcinomas Classified by Biomarkers and Correlation with Microvessel Density and VEGF Expression: A Study from Thailand

“…In comparison with the data obtained from the study of 324 Thai breast carcinomas (Chuthapisith et al, 2012) there were 59.3% luminal A, 12.3% luminal B, 13.3% HER2 and 15.1% TN while from the current study of 100 TMA cases when transformed to the comparable data there were but was significantly associated with increased risks for breast cancer-specific mortality and distant recurrence among women with luminal A tumors (Liu et al, 2011).…”

Association of Immunohistochemically Defined Molecular Subtypes with Clinical Response to Presurgical Chemotherapy in Patients with Advanced Breast Cancer

“…Gene Expression Profiling (GEP) has demonstrated that breast cancer consists of at least five distinct molecular subtypes (Perou et al, 2000;Sorlie et al, 2001). These subtypes have different risk factors (Phipps et al, 2011) and clinicopathologic features (Chang et al, 2008;Cheang et al, 2008;Liedtke et al, 2008;Smid et al, 2008;Onitilio et al, 2009;Chuthapisith et al 2012). GEP is expensive and not widely available even in the developed world.…”

Development and Validation of a Breast Cancer Risk Prediction Model for Thai Women: A Cross-Sectional Study

“…estrogen receptor(ER) and progesterone receptor (PR)) is diverse between Asian and Caucasian women. The ER+ tumor in Asian women is not as common as their Caucasian counterparts (Wiechmann et al, 2009;Telli et al, 2011;Chuthapisith et al, 2012). Previous evidences showed that ER+ tumor was associated with reproductive history (i.e., age at menarche, parity, and breastfeeding) while ER-tumor was not (Althuis et al, 2004;Tsakountakis et al, 2005).…”